Heavy! Huaier granules entered the "Report on Scientific and Technological Competitiveness of Large Varieties of Traditional Chinese Medicine (2019 Edition)" for the third time

Recently, with the support of the Chinese society of traditional Chinese medicine, the alliance of large varieties of traditional Chinese medicine, together with Wanfang data and other units, released the report on the scientific and technological competitiveness of large varieties of traditional Chinese medicine.

Large varieties of traditional Chinese medicine refer to varieties that have significant or exact clinical efficacy, meet clinical needs, have high scientific and technological content, have remarkable characteristics of traditional Chinese medicine, and occupy a large market share. The report released this time selected 579 major Chinese medicine varieties shortlisted for the evaluation of scientific and technological competitiveness in 2019 from the 59595 Chinese patent medicine products already on the market. AndHuaier GranulesWith its excellent quality, detailed scientific research data and clinical evidence, and good reputation, it stood out and was shortlisted for the third time.

Previously, in 2017 and 2018, Huaier Granules were among the "Report on Scientific and Technological Competitiveness of Large Varieties of Traditional Chinese Medicine.

Huaier granules is a national class of new anti-cancer drugs, listed so far has done a lot of basic research to clarify the efficacy of Huaier. At present, more than 500 related papers have been published, including more than 60 SCI articles. Earlier, tumor suppression, tumor cell apoptosis, angiogenesis inhibition, drug resistance reversal, drug active ingredients (monomer) and other tests were carried out. In 2017, Japanese scholar Tanaka's research found that Huaier can repair abnormal Hippo signaling pathway in cancer, thus regulating cell and tissue function, restoring stem cell and normal differentiation of heteromorphic stem cells, directly killing tumor stem cells and not affecting the proliferation of normal cells. Professor Tanaka's latest research shows that Huaier can change up to 4543 genes. These genes cover a wide range, including cell proliferation-related signaling pathways, immune system activation, neurodegeneration, and mitochondrial damage in Parkinson's disease. Wait. It can be seen that Sophora japonica is proved to be a whole gene and whole channel repair drug.

At present, Huaier particles have been included in the 2020 edition of the CSCO liver cancer diagnosis and treatment guidelines, the 2019 edition of the primary liver cancer diagnosis and treatment specifications, the 2018 Chinese liver cancer transcatheter arterial chemoembolization clinical practice guidelines and other authoritative tumor diagnosis and treatment specifications. Huaier granules have been written into the 7th/8/9 edition of "Surgery" published by People's Medical Publishing House.

At the same time, the company actively cooperated with the China Charity Federation to launch the "Huaier Granule Patient Assistance Project" on November 12, 2019 ". This project is the first drug assistance project carried out by the China Charity Federation and domestic pharmaceutical companies, and it is also the first domestic Chinese patent medicine assistance project established by the China Charity Federation. It aims to help low-and middle-income cancer patients, especially poor patients, adhere to long-term medication, standardize follow-up treatment, block tumor recurrence, and make historic contributions to human health, creating miracles of life, and revitalizing traditional Chinese medicine.